MIRANDA CLARK: Open Payments
NPI 1538899331 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,769 in 99 payments from 23 companies in 2025. Trend: 2023 $61 · 2024 $1,087 · 2025 $1,769
Food & beverage: $1,769
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $327 |
| Novo Nordisk Inc | 18 | $304 |
| ABBVIE INC. | 16 | $242 |
| PFIZER INC. | 12 | $166 |
| AstraZeneca Pharmaceuticals LP | 6 | $147 |
| Stryker Corporation | 3 | $82 |
| Collegium Pharmaceutical, Inc. | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Corium, LLC | 4 | $49 |
| Lilly USA, LLC | 2 | $43 |
Products named: CAPLYTA, Ozempic, NURTEC ODT, FARXIGA, VRAYLAR, Jornay PM, Wegovy, UBRELVY.
Industry payments across IN — which companies pay providers there.
